di Reumatologia, Società Italiana, trans. 2025. “PO:08:114 | The Adjuvanted Recombinant Zoster Vaccine Is Effective in Preventing Herpes Zoster Among Patients ≥50 Years of Age With Selected Autoimmune Diseases in the United States: A Real-World Database Analysis (2018–2021): Rosaria Silvestri1, Dagna Constenla2, Germain Lonnet3, Emmanuel Aris3, Nathalie Servotte3, Ramsanjay Rk4, Agnes Mwakingwe-Omari2, Huifeng Yun2 | 1GSK Verona, Italy; 2GSK Rockville, USA; 3GSK Wavre, Belgium; 4GSK Bengaluru, India”. Reumatismo 77 (s1). https://doi.org/10.4081/reumatismo.2025.2140.